Lieske JC, Tremaine WJ, De Simone C, O'Connor HM, Li X, Bergstralh EJ, Goldfarb DS
Again, this will vary on a case-by-case basis
These are most pronounced during dose escalation, the weeks immediately following a dose increase, and they typically diminish over time as the body adjusts
Pierpont ME, Breningstall GN, Stanley CA, Singh A : Familial carnitine transporter defect: a treatable cause of cardiomyopathy in children
doi: 10.1177/1060028020929988 53 El NouwarR.PrevostB.WautierM.YinN.HitesM.MartinyD
It has also been demonstrated that ERs are pivotal in the maintenance and functioning of oligodendrocyte progenitor cells (OPCs) and post-mitotic oligodendrocytes (OLs), respectively